Tekla Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-418,520
Closed -$9.41M 181
2023
Q1
$9.41M Hold
418,520
0.36% 58
2022
Q4
$8.8M Buy
418,520
+170,842
+69% +$3.59M 0.33% 60
2022
Q3
$6.1M Hold
247,678
0.25% 71
2022
Q2
$6M Hold
247,678
0.24% 81
2022
Q1
$6.38M Buy
247,678
+34,809
+16% +$897K 0.22% 84
2021
Q4
$6.61M Hold
212,869
0.21% 89
2021
Q3
$5.16M Hold
212,869
0.17% 105
2021
Q2
$3.11M Hold
212,869
0.1% 141
2021
Q1
$5.32M Buy
+212,869
New +$5.32M 0.18% 113
2017
Q3
Sell
-167,949
Closed -$3.26M 160
2017
Q2
$3.26M Hold
167,949
0.12% 97
2017
Q1
$3.1M Hold
167,949
0.12% 95
2016
Q4
$3.18M Sell
167,949
-162,000
-49% -$3.07M 0.14% 88
2016
Q3
$7.38M Hold
329,949
0.28% 72
2016
Q2
$5.88M Hold
329,949
0.24% 80
2016
Q1
$4.51M Hold
329,949
0.19% 92
2015
Q4
$6.37M Buy
+329,949
New +$6.37M 0.23% 81